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Clinical electrophysiology has evolved from it* infax). 
when it was confined to His bundle rccordmg t I) in a few 
research centers. to become an integral part of cardmlogy 
programs in most hospitals. This evolution is largely due 10 
ils success in diagnosing and treating Ihfe-threatemng cardrac 
arrhythmias and sudden cardiac death. Such remarkable 
progras over a span of 20 years can be attributed to 
technologic developments in the eleclrophysmlogy labora- 
tory, a better understanding of arrhythmia mechanlwn and 
effective new antiarrhythmic therapie\ mcludmg ;!bl;d on of 
the arrhythmia foci (21 and the automatic implantable car- 
dioverier-defibrillator (AICDI (31. In the IYYO; electmphvc- 
iology has come into its own a< a diwpline. 
lndueed ventricular tachyrardia/fibrillation in the electro- 
physidogy laboratory. In the western world where aschemtc 
heart disease is prevalent. more patnents are being referred 
for electrophysiologic study. and the majority of these 
patients are prone to development of recurrent ventricular 
tachycardia and ventricular fibrillation (4). Many cardiolo- 
gists consider electmphysiologic druz testing the best way of 
finding an etfective antiarrhythmic regimen for there pa- 
tients. And because it is not unusual for a patient to undergo 
three, four or even more ventricular tachycardna induction 
procedures before an effective therapy is found (if onl: 15 
found). the total number of procedures is increasing. 
Yet ventricular tachycardia induction is not risk free. 
When we began doing these studies in the early IY705. many 
of us had great reservations about inducing mahgnant ar- 
rhythmias to treat arrhythmias. ‘Then It was a novel and 
unorthodox approach: today electrophyslologwr accept I, 
.a standard practice. As we gained experience and confi- 
dence. we perhaps grew somewhat accustomed to the po- 
le”wl mhcrem risk. Bo, many of our colleugues ,n other 
\pec~alt~e\--nor to mcnrmn our patientr and their families 
\oll :u~wu~I\ aonder whether B” tnduced mahgnant ar- 
rhythms \\dl prove recalcmant to therapy. especially be- 
ciiu~e II may have to be induced <everal mnes Often patient, 
nk u\ if the\ couid d,e fmm ,b,r ,e\,. 
Death due 10 an induced arrhythmia i\ rare but it does 
hap,xn The e~acl number of patients who undergo an 
elsctrophyGologic study and develop mduccd refractory 
~cnwculdr tachycardidventricular Fibrillation is Emall. 
Horouitr I51 reported five deaths in 8.145 elecrrophyrn!ol;i 
wdw\: of rhe five pauesr, who dieo. only two had ref::c- 
wry (enlr~culx IachycarJidivcntricular fibrillation. ?G this 
!\\oc of ihe Journal Cohen et al. (6, re!ate that four panems 
had rsfrxiory ventriculartachycardiaiventncular 6br~llarmn 
and one pauent died I” a toral of I.215 consscutire ventric- 
uix rach\cdrdia induction s!udn There data come from 
leadmp. elecirophyriology labolatorio: the mortality and 
morbld8ty rata may & highsr elsewhere. Even so. why are 
lhrrc w fen deaths’! One reason is that paoents undergoing 
elccrrophywlogic studies are ucually m stable condmon: 
Iho\e aho have accondary f&ton I\uch as electrolyte im- 
balance. chronic Ibcitemra. hyporemia. acidosis) that may 
promote or worsen arrhythmias arc typically evzluded. 
Another reason II that the electrophyaiolog! id:,o-z%r! is 
designed. aalied and eqwpped to ensure prompt defihnlln- 
lion. Derpue these precautmnx. the fxl remiGns lhat a few 
paumrc uill develop mdoced refectory vsnhicular tachy- 
cardld~emr~cular fihrdlotion. and home of them will dlc. It is 
an eiecrrowhvsloloast’s worst nichtmare. one he or she 
would do &thing;o avoid. . 
The present study. Why is it sometimes very difficult to 
convert ventricular fibrillation to normal rhythm m the 
elrctruphywlogy laboratory’! It is usuai:y either becaus: !!K 
defibriliamr 15 malfunctionine or beine used incorrectlv or 
becauw the electrode pads or paddlesare incorrectly posi- 
tioned. Whatever the cause. when defibrillation fails the 
cardw arrest code may be called and. as a result, antiar- 
rhythmic ‘(gents may be administered. This sequence of 
cwnt, is troubling became antiarrhythmic drugs can in- 
crease the defibrillation threshold (7). be proarrhythmic @I. 
have negaive inotropic effects 191 and. in combination. can 
have additive adverse effects. some of them potentially 
lethal C IO). Incidentally. all four patients in the study of 
Cohen et al. (61 were receiving antiarrhytnm~c drugs and 
were given additional intravenous emergency antiarrhythmic 
medxauon. 
Whether antiarrhvthmic therapy contributed to refractory 
ventncolar tachycardialventrlcuiar Rbnllation IS not cl&. 
But my experience (11) has been that patients who develop 
protnctcd wntricolar tachycardialventricular fibrilladon 
and are given several antiarrhythmic agents do not survive. 
I am convinced. as Cohen et al. (6) point out. that antiar- 
rhythmic agents in this settmg may be not only ineffective 
but actually harmful. Unlike antwrhythmic agents. repeated 
shocks could lower the defibrillation threshold (12) and 
eventually convert the arrhythmia. A safer course is to 
cardiovert the arrbylhmia as quickly and as often as the 
defibrillator can be charged. a treatment that pives the 
patient a good chance of returning to normal sinus rhythm. 
Cohen’s group (6) mgeniously confronted the induced 
protracted ventricula, fibrillation by modifying the direct 
current ablation technique currently used to ablate ..,e AV 
node or arrhvthmia foci IO perform intracardiac defibrilla- 
tion. This simple modification successfully terminated resis- 
tant ventricular fibrillation in all patients. This leads us to ask 
why intracardiac defibrillation succeeds when our traditional 
measures fad. It may be that intracardiac defibrillation 
delivers the energy at a higher current, thereby circumvent- 
ing the increased defibrillation threshold (13). Also, intra- 
cardiac defibrillation may offsel increased transthoracic im- 
pedance caused by obesity, chronic obstructive pulmonary 
disease and other factors 1141. 
Implications. Key quest& remain. Would it be equally 
effective, but less damaging, if we delivered the shock within 
the ventricle through th; s&d or third proximal electrode? 
Doing so may defibrillate just as effectively while lessening 
the risk of myocardial injury. What should the initial energy 
level be? How much energy can we safely deliver? Is il safe 
,o deliver such high levels of energy (300 to 500 I) with use 
of cathodal shock by way of the distal electrode? When 
should this procedure be invoked? These critical questions 
must be answered, perhaps in conjunction with the pmlific 
research now being done on the AICD. 
Meanwhile, we should heed the advice of Cohen et al. (6) 
that this technique be reserved for very critical cases be. 
cause when the distal electrode contacts the endocardium, it 
injures the myocardium. as evidenced by the high creatine 
kinare enzyme levels they observed. And because most of 
the patients being treated have prior myocardial dysfunc- 
tion, additional trauma to the mvocardium mav have a 
profoundly adverse effect. 
However, considering the alternative and considering 
that the induction of severe refractory arrhythmia is the 
exception rather than the Norm, it calls for exceptional 
elTorts. Therefore, this new technique nm only is justified, 
but should be adopted by every electrophysiology labora- 
tory, together wit:, the suggested guidelines. Indeed, we 
should incmporarc the guidelines for using this procedure 
into the algorithm of rescue procedures that are now sum- 
dard practice. Doing so would help us formulate a compre. 
hensive elan to reduce this risk as much as oosrihle. All 
electrophysiology laboratories should have two detibrilla- 
ton, one hooked up to the self-adhesive electrode pads DOW 
in wide use; these pads reduce the risk of improperly 
positioned paddles that could increase transthoracic imped- 
ance. The other defibrillator should be standing by, ready to 
be used in case the first fails. If three or four translhoracic 
shocks fail, the team should immediately disconnect the 
anterior pad cable from the first defibrillator and hook it up 
to the connector. as shown in Cohen’s diagram (61, to allow 
an immediate intracavitary defibrillation cathode1 shock. 
Someone should be simultaneously charging the other de- 
fibrillator. in case it is needed. As B matter of course. ,he 
defibrillators should be regularly checked aud the staff 
trained in practice drills to continue to charge and deliver 
shocks. These measures should be codified in quality assur- 
axe manuals and practiced regularly. 
The readiness is all. Yet &en if all of this is done, 
resistant ventricular tachycardiaiventricular fibrillation will 
continue to be a part of our lives. But with a difference: 
because it can be treated we can at last rest assured that this 
bad dream will not become a reality. 
